These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3308556)

  • 1. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.
    Pyörälä K; Uusitupa M; Laakso M; Siitonen O; Niskanen L; Rönnemaa T
    Diabete Metab; 1987 Jul; 13(3 Pt 2):345-9. PubMed ID: 3308562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of macrovascular disease in diabetes mellitus.
    Jarrett RJ
    Horm Metab Res Suppl; 1985; 15():1-3. PubMed ID: 3865876
    [No Abstract]   [Full Text] [Related]  

  • 4. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
    Mazzone T
    J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is macroangiopathy a complication of diabetes mellitus? I.Hyper- insulinemia].
    Goldsztajn P
    Przegl Lek; 1990; 47(7):551-6. PubMed ID: 2284423
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperinsulinemia and atherosclerosis.
    Standl E
    Clin Invest Med; 1995 Aug; 18(4):261-6. PubMed ID: 8549011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.
    Janka HU; Ziegler AG; Standl E; Mehnert H
    Diabete Metab; 1987 Jul; 13(3 Pt 2):359-64. PubMed ID: 3308565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atherosclerosis in diabetes mellitus].
    Stange EF
    Internist (Berl); 1989 May; 30(5):297-303. PubMed ID: 2661472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of development of diabetic macroangiopathy].
    Saltykov BB
    Arkh Patol; 2001; 63(2):21-6. PubMed ID: 11392087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular growth factors and the development of macrovascular disease in diabetes mellitus.
    Koschinsky T; Bünting CE; Rütter R; Gries FA
    Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular wall and diabetes mellitus: what complications and why?].
    Marre M
    Therapie; 1997; 52(5):371-4. PubMed ID: 9501559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
    Czech A; Szczeklik Z; Przybyś W
    Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological data.
    Fontbonne A; Eschwege E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):350-3. PubMed ID: 3308563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
    Lewis GF; Steiner G
    Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.